JennisonDryden has reopened the Jennison Health Sciences Fund to new investors, having closed it in July 2005. JennisonDryden is the proprietary fund family of Prudential Financial.

“Reopening the fund gives the investment team the ability to take advantage of current market conditions,” said Scott Benjamin, senior vice president and head of product and marketing for Jennison Dryden. “A confluence of medical, regulatory, legal and market trends offers unprecedented opportunity for the fund’s seasoned healthcare team to make investment choices that give investors the potential for financial growth, particularly over the long-term.”

Specifically, the fund’s managers anticipate new product approvals, regulatory developments, and “significant mergers or partnerships and market dynamics.”

The fund seeks long-term capital appreciation by investing in the stocks of companies primarily engaged in the drug, healthcare, medicine, medical devices, and biotechnology industries.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.